Retracted: Luciferase-transfected colon adenocarcinoma cell line (DLD-1) for use in Orthotopic Xenotransplantation studies. 2012

Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
Department of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia. chemaqeel@gmail.com.

Renilla Luciferase reporter gene (rLuc) GL4.82 and GL4.13 promoter are key player in transfection, but precise knowledge of its targets in colon cancer remains limited. The aim of this study was to characterize the best transfection technique to produce a stable transfected colon DLD1 (colorectal adenocarcinoma cell line), therefore imaging based approaches were employed. DLD1 cells were transfected with a Plasmid (SV40-RLuc) carrying Renilla luciferase under the control of the SV-40 promoter, by using two different transfection techniques. Cells expressing the required DNA were isolated after antibiotic (Puramycin) selection. Clones of DLD-1/SV40-RLuc were produced using two different techniques (96 well plates and Petri dish) and their florescence intensity was recorded using IVIS machine (Calliper Life Sciences, Hopkinton, USA). Both techniques were characterized with the help of serial dilution technique. Results from this study substantiated that electroporation is the best. As expected, clones varied in their specific luciferase activity along with the dilutions. With the increase in cell concentration increase in intensity of florescence was recorded. Based on the results we are confident that this transfected cell line DLD-1/SV40-RLuc (colorectal adenocarcinoma cell line) is the best for further Orthotopic Xenotransplantation Studies and in-vivo experiments as well. Investigation shows that DLD1/SV-rLuc cells have gained little bit resistance against both drugs therefore further study is suggested to know the reasons.

UI MeSH Term Description Entries

Related Publications

Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
January 2009, Bratislavske lekarske listy,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
April 2015, Pathology oncology research : POR,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
January 1994, Anticancer research,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
December 2008, Fitoterapia,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
January 1998, Journal of cardiovascular pharmacology,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
January 2013, Asian Pacific journal of cancer prevention : APJCP,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
January 2015, Molecular and cellular biochemistry,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
October 2013, Cancer biotherapy & radiopharmaceuticals,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
March 2010, Clinical & experimental metastasis,
Muhammad Rashid Siddique, and Steve Shynder, and Muhammad Aqeel Ashraf, and Ismail Yusoff, and Abdul Wajid
August 1983, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!